Emily Von Scheven, MD

Phone: 415-476-2491
UCSF Box: 0107
Email: evonsche@peds.ucsf.edu
UCSF Profile

Project Sponsor Location(s) Topics Start End
WebSMART: Efficacy of Web-based Pain Self-Management for Adolescents with Juvenile Idiopathic Arthritis (JIA) Children's Mercy Hospital United States Pediatrics
Progression of Autoimmunity During Puberty in Systemic Lupus Erythematosis (SLE) Indiana University United States
Standardizing and Optimizing Treatment for Lupus Nephritis Duke University United States Neurology and Mental Health, Pediatrics
Outcomes of Child-onset Lupus Erythematosus: The Pediatric Lupus Outcomes Study University of Utah United States
Childhood Arthritis and Rheumatology Research Alliance Registry (CARRA Registry): Lupus Nephritis Consensus Treatment Plan Maintenance Phase Duke University United States Immunology
Rheumatology Fellowship Training Award Rheumatology Research Foundation United States Residencies, Fellowships, and Postdoctoral Training
Standardizing and Optimizing Childhood Lupus Nephritis Treatment with CARRA Arthritis Foundation United States Neurology and Mental Health
A 6 month Multi-center, Open-label Safety Study of VIMOVO in Adolescents AstraZeneca United States Immunology, Adolescent Health
Mechanisms of B Cell Responses in Autoimmune Disease: C12-ALE05-CSF Duke University United States Immunology
CARRA Registry Duke University United States
Standardizing and Optimizing Treatment for Lupus Nephritis in Children Lupus Foundation of America, Inc. United States Noncommunicable and/or Chronic Disease, Pediatrics, Systematic Reviews and Guideline Development
NP25737 A Phase I Pharmacokinetic and Safety Study of Tocilizumab (TCZ) in Patients Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis Hoffman-LaRoche, Ltd. United States Noncommunicable and/or Chronic Disease, Immunology, Pediatrics